Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-03-27
1999-07-13
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514912, A61K 31425
Patent
active
059227460
ABSTRACT:
A method and composition for altering a plausible sequence of pathological events in retinal ganglion cells associated with glaucoma, the sequence including membrane depolarization, influx of millimolar amounts of Na.sup.+ via non-inactivating Na.sup.+ channels, and the lethal elevation of cell Ca.sup.2+ due to reversal of the Na.sup.+ /Ca.sup.2+ exchanger. The method includes blocking, by administration of a selected composition, of associated, non-inactivating Na.sup.+ channels in retinal ganglion cells in order to limit Na.sup.+ /Ca.sup.+ exchange in the retinal ganglion cells and prevent buildup of the Ca.sup.2+ level in the retinal ganglion cells to a lethal level. The results in a method of preventing retinal ganglion cell death, associated with glaucoma, by administering to the optic nerve of a mammal, a compound which blocks the non-inactivating sodium ion channels of the optic nerve. Alternately, said invention relates to a method of preventing optic retinal ganglion cell death in a human by administering to the retinal ganglion cells of said human a compound which blocks the non-inactivating sodium ion channel of the retinal ganglion cells.
REFERENCES:
"Interaction Between External Na.sup.+ and Mexiletine on Na.sup.+ . . . " Ono et al. Pflugers Archiv Eur J. Phy 1995.
"Calcium: Still Center-Stage in Hypoxic-Ischemic Neuronal Death." Choi Tins vol. 18 No. 2 1995.
Protective Effects of Antiarrhythmic Agents Against Anoxic Injury . . . Stys J. Cereb Blood Flow Metab vol. 15 No. 3 1995.
"Noninactivating, Tetrodotoxin-Sensitive Na.sup.+ Conductance . . . " Stys et. al., Proc. Natl Acad Sci v90 1993.
"Arachidomc Acid Inhibits Sodium Currents and Synaptic . . . " Fraser et. al. Neuron vol. 11 1993.
"Anoxic Injury of Central Myelinated Axon: Ionic Mechanisms . . . " Ransom et. al., Rauen Press, 1993.
"Role of Na.sup.+ Conductance and the Na.sup.+ -Ca.sup.++ Exchanger in Anoxic Injury of CNS White Matter" Waxman 1992.
"Ionic Mechanisms of Anoxic Injury in Mammalian CNS White Matter: . . . " Stys et. al., J. Neur 1992.
"Role of Extra Cellular Calcium in Anoxic Injury of Mammalian . . . " Stys et. al., Proc. Natl Acad Sci v87, 1990.
"Improved Patch-Clamp Techniques for High-Resolution Current . . . " Hamill , Pflugers Archiv vol. 391 1981.
"The Extra Cellular Patch Clamp: A Method for Resolving Currents . . . " Pflugers Archiv vol. 375 1978.
Allergan
Fay Zohreh
Hackler Walter A.
LandOfFree
Inhibition of noninactivating Na channels of mammalian optic ner does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of noninactivating Na channels of mammalian optic ner, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of noninactivating Na channels of mammalian optic ner will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2276041